One of the most rewarding use-cases of AI is providing access of life changing services to minority populations who are underserved. Nowhere is this more true than in the medical field, and specifically in the quote-unquote niche field of LGBTQ Health.
Today’s guest is Dr. Roy Zucker, Director of LGBTQ Health Services at Clalit, Israel’s biggest HMO and chairman of the Israeli LGBTQ medical association.
We chat about the state of LGBTQ medicine in Israel, difficulties for LGBTQ patients trying to seek access to services and what his vision is for using AI to improve LGBTQ healthcare.
We discuss how doctors need to adapt to the AI age, and the fact that AI chatbots can provide safe spaces and be more compassionate or with less judgement to LGBTQ patients and give them services, as well as using AI for harm reduction in drug use and how that relates to getting past the safeguards of public Generative AI.
All content for Who's your Data? Podcast is the property of Gilad Barash and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
One of the most rewarding use-cases of AI is providing access of life changing services to minority populations who are underserved. Nowhere is this more true than in the medical field, and specifically in the quote-unquote niche field of LGBTQ Health.
Today’s guest is Dr. Roy Zucker, Director of LGBTQ Health Services at Clalit, Israel’s biggest HMO and chairman of the Israeli LGBTQ medical association.
We chat about the state of LGBTQ medicine in Israel, difficulties for LGBTQ patients trying to seek access to services and what his vision is for using AI to improve LGBTQ healthcare.
We discuss how doctors need to adapt to the AI age, and the fact that AI chatbots can provide safe spaces and be more compassionate or with less judgement to LGBTQ patients and give them services, as well as using AI for harm reduction in drug use and how that relates to getting past the safeguards of public Generative AI.
Ep18: Femtech - Women's Health Data in a Post Roe V. Wade World
Who's your Data? Podcast
50 minutes 27 seconds
2 years ago
Ep18: Femtech - Women's Health Data in a Post Roe V. Wade World
Femtech - or Female Health Technology, which includes apps such as period trackers, is experiencing unprecedented growth. But nowhere is this podcast’s tagline - how life affects data and how data affects life - more relevant than in this industry in the shadow of the Dobbs decision by the supreme court overturning Roe V. Wade this year.
In this episode I talk to Bethany Corbin, a Femtech innovation and data privacy attorney, about the Femtech industry and its challenges in a post Roe V. Wade world - what kind of data do these apps collect? What are the unique data privacy concerns and how these were affected by Dobbs?
Bethany discusses The calls to delete period tracking apps and other reactions to Dobbs, some actual cases of data privacy violations and gives tips on how to vet such apps to make sure they are compliant with stringent privacy standards. We also touch on data aggregation and utilizing AI in this space. I hope you enjoy this fascinating and timely conversation.
Who's your Data? Podcast
One of the most rewarding use-cases of AI is providing access of life changing services to minority populations who are underserved. Nowhere is this more true than in the medical field, and specifically in the quote-unquote niche field of LGBTQ Health.
Today’s guest is Dr. Roy Zucker, Director of LGBTQ Health Services at Clalit, Israel’s biggest HMO and chairman of the Israeli LGBTQ medical association.
We chat about the state of LGBTQ medicine in Israel, difficulties for LGBTQ patients trying to seek access to services and what his vision is for using AI to improve LGBTQ healthcare.
We discuss how doctors need to adapt to the AI age, and the fact that AI chatbots can provide safe spaces and be more compassionate or with less judgement to LGBTQ patients and give them services, as well as using AI for harm reduction in drug use and how that relates to getting past the safeguards of public Generative AI.
